Citation

Banerjee A, Choi H, DeVogel N, Xu Y, Yoganandan N. Front. Bioeng. Biotechnol. 2020; 8: e877.

Copyright

(Copyright © 2020, Frontiers Media)

DOI

10.3389/fbioe.2020.00877

PMID

32850734 PMCID

Abstract

Injury risk curves (IRCs) represent the quantification of risk of adverse outcomes, such as a bone fracture, quantified by a biomechanical metric such as force or deflection. From a biomechanical perspective, they are crucial in crashworthiness studies to advance human safety. In clinical settings, they can be used as an assistive tool to aid in the decision-making process for surgical or conservative treatment. The estimation of risk corresponding to a level of biomechanical metric is done using a regression technique, such as a parametric survival regression model. As with any statistical procedure, error measures are computed for the IRC, representing the quality of the estimated risk. For example, confidence intervals (CIs) are recommended by the International Standards Organization, and the normalized confidence interval width (NCIW) is computed based on the width of the CI. This is a surrogate for the quality of the risk curve. A 95% CI means that if the same experiment were hypothetically repeated 100 times, at least 95 of the computed CIs should contain the true risk curve. Such an interpretation is problematic in most biomechanical contexts as rarely the same experiment is repeated. The notion that a wider confidence interval implies a poorer quality risk curve can be misleading. This article considers the evaluation of CIs and its implications in biomechanical settings for safety engineering and clinical practice. Alternatives are suggested for future studies.

Language: en

Keywords

confidence intervals; injury risk curves; NCIS quality measures; resampling; survival analysis